Skip to main content
Premium Trial:

Request an Annual Quote

Michael Schubert, Tony Pawson, Peter Singer, Eric Lander, Douglas Morton, Boyd Mulvey, Victor Markowitz

Premium

Michael Schubert has been promoted to vice president for R&D at Bruker Daltonics. Previously, he was responsible for Bruker Daltonics’ R&D activities in Bremen, Germany, and served as managing director of Bruker Daltonik in Bremen and Leipzig. Schubert holds a doctorate in physics from the University of Hamburg in Germany.


Tony Pawson and Peter Singer have won Excellence in Health Research Awards from the Canadian Institutes of Health Research. Pawson is a proteomics researcher at the Samuel Lunenfeld Research Institute at Mount Sinai Hospital in Toronto. Singer is a bioethicist at the University of Toronto and has been studying the impact of genomics in developed and developing countries.


Eric Lander has joined the faculty of the systems biology department at Harvard Medical School. He is also the director of the Broad Institute and a professor at MIT.


Douglas Morton has been appointed to the board of directors of Paradigm Genetics. Morton is the CEO of the Southwest Michigan Innovation Center and former vice president of Pfizer. Morton was vice president of Pfizer until he retired in 2003. Prior to that he held a variety of different positions at Upjohn, Pharmacia, and finally Pfizer. He holds an AB in chemistry from Kenyon College and a PhD in organic chemistry from Columbia University.


Boyd Mulvey has been appointed to the board of directors of NextGen Sciences. Mulvey is the CEO and founder of Create Partners, which just completed a round of investment in NextGen, the company announced this week. Mulvey has worked at the board level of several financial institutions, including CSFP and UBS.


Victor Markowitz has become chief informatics officer at the US Department of Energy Joint Genome Institute. Prior to joining JGI, he was chief information officer and senior vice president for data management systems at Gene Logic. Markowitz also heads the Biological Data Management and Technology Center within the Computational Research Division at Lawrence Berkeley National Laboratory. He holds DSc and MSc degrees in computer science from Technion at the Israel Institute of Technology in Haifa, Israel.

 

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.